Skip to Main Content

Paper Details

Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.
Breast Cancer Res
5
2021
; variant, A allele, Breast Cancer, ER, ER-negative tumors, ER-positive tumors, breast cancer, breast tumors, common, germline genetic variants, germline variants, grade 3 tumors, loci, patient, patients, rs1106333, rs4679741, rs5934618, rs78754389, tumor
Author NameAffiliation
Jonathan BeesleyQIMR Berghofer Medical Research Institute
Jonathan BeesleyQIMR Berghofer Medical Research Institute
Sander CanisiusThe Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Sander CanisiusThe Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Irene L AndrulisLunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics
Irene L AndrulisUniversity of Toronto
Irene L AndrulisLunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics
Irene L AndrulisUniversity of Toronto
Hoda Anton-CulverGenetic Epidemiology Research Institute, University of California Irvine
Hoda Anton-CulverGenetic Epidemiology Research Institute, University of California Irvine
Paul L AuerFred Hutchinson Cancer Research Center
Paul L AuerZilber School of Public Health, University of Wisconsin-Milwaukee
Sabine BehrensGerman Cancer Research Center (DKFZ)
Federico CanzianGerman Cancer Research Center (DKFZ)
Jenny Chang-ClaudeGerman Cancer Research Center (DKFZ)
Jenny Chang-ClaudeUniversity Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Christine L ClarkeWestmead Institute for Medical Research, University of Sydney
Christine L ClarkeWestmead Institute for Medical Research, University of Sydney
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Laure Dossus
Alison M DunningUniversity of Cambridge
Peter A FaschingComprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU)
Peter A FaschingUniversity of California at Los Angeles, David Geffen School of Medicine
Graham G Giles
Graham G GilesSchool of Clinical Sciences at Monash Health, Monash University
Graham G GilesThe University of Melbourne
Christopher A HaimanKeck School of Medicine, University of Southern California
Christopher A HaimanKeck School of Medicine, University of Southern California
Per HallKarolinska Institutet
Per Hall
David J HunterHarvard T.H. Chan School of Public Health
David J HunterUniversity of Oxford
David J HunterHarvard T.H. Chan School of Public Health
David J HunterUniversity of Oxford
Esther M JohnStanford University School of Medicine
Esther M JohnStanford Cancer Institute, Stanford University School of Medicine
Rudolf KaaksGerman Cancer Research Center (DKFZ)
Peter KraftHarvard T.H. Chan School of Public Health
Peter KraftHarvard T.H. Chan School of Public Health
Peter KraftHarvard T.H. Chan School of Public Health
Peter KraftHarvard T.H. Chan School of Public Health
Vessela N KristensenUniversity of Oslo
Vessela N KristensenOslo University Hospital and University of Oslo
James V Lacey
James V LaceyCity of Hope Comprehensive Cancer Center
James V Lacey
James V LaceyCity of Hope Comprehensive Cancer Center
  • 1 - 50

Datasets